NP Istanbul Brain Hospital
| Түркия | Австрия | Испания | |
| Стационарлық емделу (1 күнге) | бастап $350 | бастап $1,200 | бастап $800 |
| Сопровождаушының болуы (1 күнге) | бастап $50 | бастап $150 | бастап $100 |
Сіз Bookimed қызметтері үшін төлемейсіз. Сайттағы стационарлық емделуді (1 күнге) бағалары клиниканың баға тізіміне сәйкес келеді. Сіз жеткенде тікелей клиникада төлейсіз. Бөліктермен төлеу қолжетімді.
Bookimed Сіздің қауіпсіздігіңізді қамтамасыз етеді. Біз тек стационарлық емделудің (1 күнге) жүргізу үшін жоғары халықаралық стандарттарға сәйкес келетін клиникалармен ғана жұмыс істейміз. Олардың бүкіл әлем бойынша халықаралық науқастарға қызмет көрсету үшін қажетті лицензиялары бар.
Bookimed тегін көмек және қолдау ұсынады. Жеке медициналық координатор сапарға дейін, кезінде және кейін Сізбен байланыста. Стационарлық емделу (1 күнге) процедурасы кезінде Сіз басқа елде жалғыз қалмайсыз.
Prof. Amos Toren, MD, PhD, MHA, is a pediatric hemato-oncologist and BMT specialist. He served as Director of Pediatric Hemato-Oncology and BMT at Sheba Medical Center.
He is board certified in Pediatrics, Pediatric Hemato-Oncology, and Bone Marrow Transplantation. He holds a PhD in Human Genetics. He was Head of the Hematology Division at Tel Aviv University for two terms. He is a member of ASH, COG, ESPHI, EBMT, and CIBMTR. He also serves on the Ministry of Health Cord Blood Committee.
He led one of Israel’s most advanced pediatric oncology and BMT programs. The program treated children and young adults. His focus includes leukemia and lymphoma, immunodeficiencies, and rare cancers. He specializes in BMT and CAR T-cell therapy.
His translational research covers CAR T cells, cytokine-induced killer cells, pediatric brain tumors, and targeted therapies. He has worked with St. Anna, the NIH, and St. Jude. His publications include studies on pediatric SCT prophylaxis and PARP resistance.
Dr. Hana Golan, MD, heads the Pediatric Hemato-Oncology and Bone Marrow Transplantation (BMT) Division at Sheba Medical Center. She specializes in childhood cancers, with a focus on neuroblastoma and other high-risk solid tumors.
She leads one of the region’s most advanced pediatric oncology programs. She manages complex, high-risk cases and practices at a hospital ranked in the global top 10.
She is the principal investigator of the High-Risk Neuroblastoma ESIOP protocol. She serves as an investigator in international Phase I/II trials and as the national coordinator of multicenter oncology protocols. She led the development of computerized chemotherapy protocols and patient databases to improve safety.
She earned her MD from the Technion. She completed residencies in pediatrics and pediatric hemato-oncology at Sheba. She conducted advanced research in transplantation immunology at the Weizmann Institute. She is board-certified in Pediatrics and Pediatric Hematology-Oncology. She is a Senior Lecturer at the Sackler Faculty of Medicine, Tel Aviv University. Her research focuses on cancer stem cells, targeted therapies, treatment-resistant malignancies, and cannabinoid-related oncology.
Dr. Łukasz Maciejewski is a specialist in anesthesiology and intensive care medicine and in emergency medicine. He graduated from the Pomeranian Medical University in Szczecin. He completed additional training in Poland and Germany.
He gained clinical experience at the 109th Military Hospital in Szczecin. He also worked in German centers: Vivantes Klinikum im Friedrichshain (Berlin), Kreiskrankenhaus Wolgast gGmbH, and Asklepios Klinikum Uckermark (Schwedt/Oder).
He holds DEGUM certifications in ultrasonography and regional anesthesia (German Society for Ultrasound in Medicine). He supervises apheresis procedures at Nowoczesna Afereza. He speaks Polish, German, and English.
Доктор Милена Коларова 2012 жылдан бастап Altoa | Бероун оңалту ауруханасының оңалту бөлімін басқарып келеді, оның оңалтудың әртүрлі салаларында мол тәжірибесі бар.